Characterization of Dasatinib Pharmacokinetics and Exposure-Response In Support of Dose Recommendations in Pediatric Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph plus CML) In Chronic Phase (CP)